Director/Senior Director Medical Affairs EMEA

Scholar Rock is delivering muscle-targeted breakthroughs to transform the treatment of spinal muscular atrophy (SMA) and other rare neuromuscular diseases where muscle atrophy remains a critical unmet need. As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the biopharmaceutical company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. Scholar Rock works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more about our neuromuscular franchise at ScholarRock.com and follow @ScholarRock on X and on LinkedIn. Summary of Position: Position Responsibilities Co-create the medical strategy, together with the EMEA Medical lead and global medical relevant stakeholders, and drive the execution of EMEA medical plans in alignment with global strategic imperatives. Develop strong partnerships with the external SMA community, supporting and active participating in key academic, research and/or clinical care forums. Lead the strategy, development, and execution of key above-market initiatives, including regional advisory boards and preceptorship programs. Act as subject matter expert in medical review processes to support development and localization of EMEA external and field materials Build and implement engagement and communication plan in partnership with key internal stakeholders (e.g. Global scientific communication teams) t, as well as co-lead with global teams the implementation of associated medical education initiatives when applicable (e.g. medical symposia) Co-create and define and drive the EMEA RWE strategy in alignment with global priorities and execute EMEA regional evidence generation plans in close partnership with key stakeholders (e.g. Global Evidence Generation Team and Local medical teams). Ensure that RWE collaborations are designed to be fit-for-purpose, uphold the highest standards of scientific and regulatory rigor, and deliver high-quality, credible evidence that supports stakeholders’ requirements Together with global medical evidence teams, establish and maintain strategic relationships with registry leaders, KOLs, and relevant groups, forging long-term collaborations with academic and data consortia Oversee initiation and delivery of RWE projects with European/EMEA registry and academic partners, ensuring feasibility, timely execution, and measurable impact Provide oversight of European/EMEA Investigator-Initiated Studies (IISs) and independent research requests, aligning external research with evidence generation priorities Facilitates sharing of best practices and knowledge across the organization, supporting the coordination of insights collection and reports Candidate Requirements Advanced degree (Pharm.D., Ph.D., M.D) required 10+ years of related work experience in medical affairs related industry roles. Rare disease experience preferred Ability to think strategically and proven records of executing complex initiatives with pragmatism and customer focus Experience in executing medical regional initiatives such as advisory boards and evidence generation projects Proven track record of success establishing, building and maintaining scientific engagement with influential academic and clinical experts Knowledge of relevant EU compliance and regulatory guidelines Ability to summarize complex information and present in a clear, concise, and scientifically accurate manner to a range of audiences Proven track record of excellent communication and collaboration skills, including recognition by cross-functional partners; work well independently while exhibiting professional maturity, confidence, and competence Ability to travel 30-50%. Weekend travel may be required according to conference / congress dates Commitment to adhere to company values / policies and comply with ethical / compliance standards